Skip to content

Drug interactions

Lorlatinib + Ospemifene

Severity: Moderate

Lorlatinib and Ospemifene: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Ospemifene is metabolized by CYP3A4 and CYP2C9, and inducers lower its exposure. Lorlatinib may reduce its efficacy for dyspareunia.

What this interaction means in plain words

Lorlatinib and Ospemifene can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Lorlatinib belongs to Oncology; Ospemifene belongs to Endocrine.

Evidence level: Low

Why it happens

Lorlatinib induces CYP3A4, increasing ospemifene metabolism.

What to do

Monitor symptom relief and consider an alternative therapy if response is lost.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Lorlatinib and Ospemifene, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Lorlatinib with Ospemifene?

MediHelp rates the interaction as moderate. Lorlatinib and Ospemifene can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Ospemifene is metabolized by CYP3A4 and CYP2C9, and inducers lower its exposure. Lorlatinib may reduce its efficacy for dyspareunia.

How serious is the interaction between Lorlatinib and Ospemifene?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor symptom relief and consider an alternative therapy if response is lost.

What other medicines interact with Lorlatinib?

MediHelp also lists interactions of Lorlatinib with, for example, Amobarbital, Apalutamide, Butabarbital. The full list is on the Lorlatinib page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in